FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to the field of medicine. Composition containing microparticles of glucagons-like peptide 1 (GLP-1) in combination with diketopiperazine (DKP) is stable in vitro and in vivo. Composition may be used as pharmaceutical preparation to treat diseases or conditions, including, but not limited to, diabetes, cancer and obesity.
EFFECT: invention provides for minimum risk in case of intrapulmonic administration.
24 cl, 31 dwg, 20 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS, CONTAINING GLUCAGON-LIKE PEPTIDE 1 (GLP-1) | 2007 |
|
RU2542500C2 |
| METHOD FOR PREVENTING GLP-1 SIDE EFFECTS | 2008 |
|
RU2474415C2 |
| ACTIVE SUBSTANCE DELIVERY | 2008 |
|
RU2467741C2 |
| METHOD FOR PREPARING DRUG BASED ON HIGHER AFFINITY OF ACTIVE AGENTS TO CRYSTALLINE MICROPARTICLE SURFACES | 2006 |
|
RU2390325C2 |
| DIKETOPIPERAZIN MICROPARTICLES WITH PARTICULAR AMOUNT OF ISOMERS | 2010 |
|
RU2490026C1 |
| SYSTEMS AND METHODS FOR DRY POWDER DRUG DELIVERY | 2011 |
|
RU2571331C1 |
| SYSTEMS AND METHODS FOR DRY POWDER DRUGS DELIVERY | 2011 |
|
RU2531455C2 |
| METHOD OF IMPROVING PHARMACEUTICAL PROPERTIES OF PARTICLES, CONTAINING DIKETOPIPERAZINE AND ACTIVE AGENT | 2007 |
|
RU2403059C2 |
| DRY POWDER DRUG DELIVERY SYSTEMS AND METHODS | 2013 |
|
RU2650035C2 |
| METHOD FOR PREPARING DRUG COMPOSITION BASED ON INCREASING ACTIVE AGENT AFFINITY OF CRYSTALLINE MICROPARTICLE SURFACES | 2010 |
|
RU2443414C2 |
